(Q50521325)

14 March 2018

title

The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. (English)

1 reference

14 March 2018

1 reference

1 reference

Ai Peng

1

1 reference

14 March 2018

Ting Ye

2

1 reference

14 March 2018

Dinesh Rakheja

3

1 reference

14 March 2018

Yangke Tu

4

1 reference

14 March 2018

Tao Wang

5

1 reference

14 March 2018

Yong Du

6

1 reference

14 March 2018

Jason K Zhou

7

1 reference

14 March 2018

Nosratola D Vaziri

8

1 reference

14 March 2018

Zhao Hu

9

1 reference

14 March 2018

Chandra Mohan

10

1 reference

14 March 2018

Xin J Zhou

11

1 reference

14 March 2018

language of work or name

English

0 references

publication date

4 May 2011

1 reference

14 March 2018

published in

Kidney International

1 reference

14 March 2018

volume

80

1 reference

14 March 2018

issue

6

1 reference

14 March 2018

page(s)

601-611

1 reference

14 March 2018

Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Pathogenesis of Goodpasture syndrome: a molecular perspective.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Free radicals and antioxidants in normal physiological functions and human disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Oxidants in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Chemoprevention of lung cancer by tea.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Inhibition of NADPH oxidase subunits translocation by tea catechin EGCG in mast cell

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Preferential inhibition by (-)-epigallocatechin-3-gallate of the cell surface NADH oxidase and growth of transformed cells in culture

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Sepsis, leukocytes, and nitric oxide (NO): an intricate affair.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Direct scavenging of nitric oxide and superoxide by green tea.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Resolution of renal inflammation: a new role for NF-kappaB1 (p50) in inflammatory kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Mechanisms of cancer prevention by green and black tea polyphenols

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Osteopontin expression in human crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

De novo glomerular osteopontin expression in rat crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Protection of the kidney by thiazolidinediones: an assessment from bench to bedside

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)? activators

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Rosiglitazone decreases albuminuria in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Reduction of proteinuria by rosiglitazone in non-diabetic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Strain distribution pattern of susceptibility to immune-mediated nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Excreted urinary mediators in an animal model of experimental immune nephritis with potential pathogenic significance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Plasma creatinine and creatine quantification by capillary electrophoresis diode array detector

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FKI.2011.121

7 January 2021

Identifiers

DOI

10.1038/KI.2011.121

1 reference

14 March 2018

1 reference

14 March 2018